Selective small-molecule inhibition of an RNA structural element

  • Nature. 2015 Oct 29;526(7575):672-7. doi: 10.1038/nature15542.
John A Howe  1 Hao Wang  1 Thierry O Fischmann  1 Carl J Balibar  1 Li Xiao  1 Andrew M Galgoci  1 Juliana C Malinverni  1 Todd Mayhood  1 Artjohn Villafania  1 Ali Nahvi  2 Nicholas Murgolo  1 Christopher M Barbieri  1 Paul A Mann  1 Donna Carr  1 Ellen Xia  1 Paul Zuck  3 Dan Riley  3 Ronald E Painter  1 Scott S Walker  1 Brad Sherborne  1 Reynalda de Jesus  1 Weidong Pan  1 Michael A Plotkin  1 Jin Wu  1 Diane Rindgen  1 John Cummings  1 Charles G Garlisi  1 Rumin Zhang  1 Payal R Sheth  1 Charles J Gill  1 Haifeng Tang  1 Terry Roemer  1
Affiliations
  • 1. Merck Research Laboratories, Kenilworth, New Jersey 07033, USA.
  • 2. Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
  • 3. Merck Research Laboratories, North Wales, Pennsylvania 19454, USA.
Abstract

Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene expression. As such, riboswitches serve as a novel, yet largely unexploited, class of emerging drug targets. Demonstrating this potential, however, has proven difficult and is restricted to structurally similar antimetabolites and semi-synthetic analogues of their cognate ligand, thus greatly restricting the chemical space and selectivity sought for such inhibitors. Here we report the discovery and characterization of ribocil, a highly selective chemical modulator of Bacterial riboflavin riboswitches, which was identified in a phenotypic screen and acts as a structurally distinct synthetic mimic of the natural ligand, flavin mononucleotide, to repress riboswitch-mediated ribB gene expression and inhibit Bacterial cell growth. Our findings indicate that non-coding RNA structural elements may be more broadly targeted by synthetic small molecules than previously expected.

Products